Today’s Solutions: November 30, 2022

A new method of detecting early-stage cancer is getting the green light from the FDA, meaning human trials will commence in the coming two years. The new imaging method was intended for detecting metastatic cancer in the liver, but the researchers say it could be applied to a number of other types of cancer.

The new study, published in the journal Science Advances, describes the development of a new MRI contrast agent that combines MRI image-enhancing gadolinium with a novel protein designed to hone in on and bind to CXCR4 receptors.

Yes, that might sound like a whole lot of medical jargon, but basically these receptors are known to be over-expressed in the presence of metastatic cancer. The new imaging method can detect these receptors, something which was previously not possible. By doing this, cancer can be detected earlier, thus improving the success rate of applied treatments.

Of course, we shouldn’t get too ahead of ourselves as this new method goes to human trials, but we’ll certainly be keeping an eye out for its development.

Solutions News Source Print this article
More of Today's Solutions

The Domino effect: pizza place splurges on electric delivery fleet

Domino's Pizza is investing in a fleet of 800 electric Chevrolet Bolts painted in Domino's livery to supplement its understaffed driving crew. As the ...

Read More

Germany is turning 62 Cold War military bases into sanctuaries for wildlife

Wildlife in Germany will get a quarter more land to roam over, as the country’s government has decided to turn 62 unused military bases ...

Read More

The case for shifting to a four-day workweek for post-pandemic life

At The Optimist Daily, we’re putting a lot of focus on what the world can do after the pandemic to create a healthier, more ...

Read More

Try these yoga poses for deeper sleep

Yoga is a practice meant to boost mindfulness and physical wellness, so it’s no surprise that it can also improve sleep. If you’re one ...

Read More